A clinical study to evaluate Flunil ACP Capsule for treatment of Respiratory Tract Infectio
- Conditions
- Health Condition 1: J069- Acute upper respiratory infection,unspecified
- Registration Number
- CTRI/2021/08/035970
- Lead Sponsor
- Amitojas Wellness Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Male and female subjects aged 18 years and above.
2. Subjects with upper respiratory tract infections similar to flu.
3. Subjects willing to provide informed written consent.
1. Pregnant, planning to become pregnant or breastfeeding women.
2. Subjects with significant medical/surgical condition which requires long-term treatment.
3. Subjects who are currently being treated with other immunostimulant drugs.
4. Current or past history of a serious illness including, seizures, major psychiatric illness, structural brain disease, liver or kidney failure, organ transplantation, rheumatoid arthritis, uncontrolled hypertension, uncontrolled diabetes or malignancy, cardiovascular event in the last three months.
5. Alcohol or substance abuse
6. Allergy or sensitivity to any of the ingredients in the study treatment
7. Subjects who have participated in other clinical studies during the past 3 months or subjects who intend to participate in other clinical studies parallelly.
8. Subjects with any other illness or health condition which in the opinion/medical judgement of the study investigator makes the subject ineligible to participate in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method